Candida bloodstream infection in neonates.
Neonatal candidemia is poorly understood and is a leading cause of nosocomial infectious mortality in the nursery. Prevention of candidemia has been difficult, although a combined approach of antifungal prophylaxis and targeted empirical therapy may eventually reduce morbidity and mortality. Multicenter prospective testing of an integrated approach to early diagnosis of neonatal candidemia using newer molecular techniques is also needed. Candidemia in the infant is cause for prompt removal (or replacement) of central vascular catheters and institution of antifungal therapy. End-organ evaluation is also probably warranted to guide treatment and facilitate prognostication. Given the continuing progress in clinical research infrastructure and development of new diagnostic tests and antifungal agents, substantial improvement in the prevention, diagnosis, and management of neonatal candidemia is plausible over the next decade.
Benjamin
Daniel K
DK
Department of Pediatrics, Duke University, Durham, NC, USA. danny.benjamin@duke.edu
Garges
Harmony
H
Steinbach
William J
WJ
D002175:Candida / Q000302:isolation & purification; D002177:Candidiasis / Q000517:prevention & control*; D003428:Cross Infection / Q000517:prevention & control*; D016469:Fungemia / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal